Shiloh
Editor, Senior Moderator
Source: https://www.cbc.ca/news/canada/toronto/covid-19-ontario-september-29-moore-briefing-update-1.6193455
'Mild risk' prompts Ontario to recommend Pfizer over Moderna for those aged 18-24
'I hope the public will realize we're trying to be as transparent as possible,' says Dr. Kieran Moore
CBC News · Posted: Sep 29, 2021 10:48 AM ET | Last Updated: 2 hours ago
An increase in cases of a rare heart condition in young adults who have received the COVID-19 Moderna vaccines has prompted Ontario to recommend the Pfizer-BioNTech shots for those aged 18 to 24 "out of an abundance of caution."
The province says the rise of myocarditis and pericarditis cases has been particularly observed among men in that age group. Between June and August, the province says the risk of myocarditis and pericarditis for men aged 18 to 24 following a second dose of Moderna was one in 5,000. There have been no fatalities.
"I'm not holding any facts back, there is a risk," said Dr. Kieran Moore, Ontario's chief medical officer of health.
In comparison, the risk of myocarditis and pericarditis for people who received the Pfizer-BioNTech vaccine was one in 28,000.
However, Moore stressed that Moderna's elevated risk is "very mild" and that two of his three young sons are in the 18-24 age range and both received the vaccine with "no concerns."
"Moderna is an excellent product," he said. "I've complete confidence in it."...
'Mild risk' prompts Ontario to recommend Pfizer over Moderna for those aged 18-24
'I hope the public will realize we're trying to be as transparent as possible,' says Dr. Kieran Moore
CBC News · Posted: Sep 29, 2021 10:48 AM ET | Last Updated: 2 hours ago
An increase in cases of a rare heart condition in young adults who have received the COVID-19 Moderna vaccines has prompted Ontario to recommend the Pfizer-BioNTech shots for those aged 18 to 24 "out of an abundance of caution."
The province says the rise of myocarditis and pericarditis cases has been particularly observed among men in that age group. Between June and August, the province says the risk of myocarditis and pericarditis for men aged 18 to 24 following a second dose of Moderna was one in 5,000. There have been no fatalities.
"I'm not holding any facts back, there is a risk," said Dr. Kieran Moore, Ontario's chief medical officer of health.
In comparison, the risk of myocarditis and pericarditis for people who received the Pfizer-BioNTech vaccine was one in 28,000.
However, Moore stressed that Moderna's elevated risk is "very mild" and that two of his three young sons are in the 18-24 age range and both received the vaccine with "no concerns."
"Moderna is an excellent product," he said. "I've complete confidence in it."...